COM:G1THERAPEUTICS
G1 Therapeutics, Inc.
- Stock
Last Close
3.95
26/07 20:00
Market Cap
145.87M
Beta: -
Volume Today
486.89K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 1.04M - | 522K 49.94% | 45.28M - | 31.48M 30.49% | 51.30M 62.98% | 82.51M 60.84% | |||||
cost of revenue | 5.02M - | 356K - | 2.02M - | 3.75M 85.91% | 7.20M 91.97% | ||||||
gross profit | -3.98M - | 522K 113.13% | -356K - | 45.28M 12,820.51% | 29.46M 34.95% | 47.55M 61.42% | 75.32M 58.38% | ||||
selling and marketing expenses | |||||||||||
general and administrative expenses | 2.70M - | 3.22M 19.04% | 5.23M 62.61% | 7.09M 35.52% | 18.60M 162.49% | 40.04M 115.23% | 68.49M 71.06% | ||||
selling general and administrative expenses | 2.70M - | 3.22M 19.04% | 5.23M 62.61% | 7.09M 35.52% | 18.60M 162.49% | 40.04M 115.23% | 68.49M 71.06% | 95.69M 39.72% | 100.42M 4.94% | 71.13M 29.16% | |
research and development expenses | 5.02M - | 12.73M 153.63% | 25.16M 97.65% | 53.88M 114.14% | 70.68M 31.18% | 89.00M 25.92% | 73.27M 17.67% | 76.22M 4.03% | 83.32M 9.30% | 43.71M 47.54% | |
other expenses | 18K - | 182.37K 913.18% | 888K 386.92% | 4.00M 350.23% | 6.59M 64.93% | -542K 108.22% | -346K 36.16% | 3K 100.87% | 2.24M 74,566.67% | ||
cost and expenses | 7.72M - | 15.95M 106.56% | 30.39M 90.59% | 60.97M 100.61% | 89.29M 46.45% | 129.04M 44.53% | 141.76M 9.86% | 173.93M 22.69% | 187.48M 7.79% | 122.04M 34.91% | |
operating expenses | 2.70M - | 15.95M 490.41% | 30.39M 90.59% | 60.97M 100.61% | 89.29M 46.45% | 129.04M 44.53% | 141.76M 9.86% | 171.92M 21.27% | 183.73M 6.87% | 114.84M 37.49% | |
interest expense | 1.78M - | 4.67M 162.49% | 10.43M 123.53% | 10.04M 3.78% | |||||||
ebitda | -6.66M - | -10.53M 58.01% | -30.24M 187.33% | -60.84M 101.17% | -89.29M 46.76% | -129.04M 44.53% | -96.07M 25.55% | -142.76M 48.61% | -134.90M 5.51% | -39.01M 71.08% | |
operating income | -6.68M - | -15.42M 130.96% | -30.39M 97.04% | -60.97M 100.61% | -89.29M 46.45% | -129.04M 44.53% | -96.48M 25.24% | -142.46M 47.66% | -136.18M 4.41% | -39.53M 70.97% | |
depreciation and amortization | 17.31K - | 42K 142.58% | 67.23K 60.06% | 89K 32.39% | 175K 96.63% | 356K 103.43% | 410K 15.17% | -303K 173.90% | 1.28M 522.77% | 513K 59.95% | |
total other income expenses net | -64 - | -4.84M 7,560,837.50% | 100.14K 102.07% | 847K 745.81% | 4.00M 372.02% | 6.59M 64.93% | -1.37M 120.75% | -4.97M 263.30% | -9.68M 94.79% | -5.33M 45.00% | |
income before tax | -6.68M - | -20.26M 203.42% | -30.29M 49.49% | -60.12M 98.48% | -85.29M 41.86% | -122.45M 43.57% | -97.84M 20.09% | -147.43M 50.68% | -145.86M 1.06% | -44.85M 69.25% | |
income tax expense | 502.36K - | 4.86M 866.83% | 82.23K 98.31% | 41K 50.14% | 4.00M 9,651.22% | -356K 108.90% | 1.41M 496.07% | 925K 34.40% | 1.70M 83.78% | 3.12M 83.24% | |
net income | -7.18M - | -20.26M 182.19% | -30.29M 49.49% | -60.12M 98.48% | -85.29M 41.86% | -122.09M 43.15% | -99.25M 18.70% | -148.35M 49.47% | -147.56M 0.53% | -47.97M 67.49% | |
weighted average shs out | 1.23M - | 20.43M 1,564.64% | 20.43M 0% | 18.20M 10.92% | 33.32M 83.08% | 37.50M 12.55% | 37.88M 1.01% | 41.94M 10.73% | 43.63M 4.01% | 51.73M 18.58% | |
weighted average shs out dil | 1.23M - | 20.43M 1,564.64% | 20.43M 0% | 18.20M 10.92% | 33.32M 83.08% | 37.50M 12.55% | 37.88M 1.01% | 41.94M 10.73% | 43.63M 4.01% | 51.73M 18.58% | |
eps | -5.85 - | -0.99 83.08% | -1.48 49.49% | -3.30 122.97% | -2.56 22.42% | -3.26 27.34% | -2.62 19.63% | -3.54 35.11% | -3.38 4.52% | -0.93 72.49% | |
epsdiluted | -5.85 - | -0.99 83.08% | -1.48 49.49% | -3.30 122.97% | -2.56 22.42% | -3.26 27.34% | -2.62 19.63% | -3.54 35.11% | -3.38 4.52% | -0.93 72.49% |
All numbers in (except ratios and percentages)